Worldwide, breast cancer is the most common cancer among women (Ferlay et al., 2015). Based on data from the Global Cancer Statistics 2018, it accounted for nearly 2.1 million newly diagnosed cancer cases in 185 countries (Bray et al., 2018). In China, from 2009 to 2011, breast cancer cases were estimated to be around 15.1% of all newly diagnosed cancer cases (Chen et al., 2016), and it is predicted that 2.5 million new cases of breast cancer will be diagnosed among Chinese women by 2021 (Linos et al., 2008). Particularly, mastectomy has played an important role in this field, and it currently ranks among the most common treatments. In recent reports from Saudi Arabia (Al-Gaithy et al., 2019) and Brazil (Balabram et al., 2012), its rates ranged from 62.4% to 64.6% of all procedures related to breast cancer in 2011 (Brazil) and 2018 (Saudi Arabia); in some provinces of China (Huang et al., 2016;Lu et al., 2015), these numbers went as high as 80.41%-81.7% in 2014.Notwithstanding, such surgery procedures often cause many adverse effects towards breast cancer survivors' physical, psychological and spiritual health in the postsurgery period. Previous studies demonstrated that breast cancer surgery survivors could experience nausea and vomiting (Wesmiller et al., 2017